{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:14:57Z","timestamp":1758039297818,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ad.2014.09.003","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T22:47:52Z","timestamp":1419029272000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tratamiento combinado con etanercept y f\u00e1rmacos sist\u00e9micos\/fototerapia en psoriasis"],"prefix":"10.1016","volume":"106","author":[{"given":"M.","family":"Ara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pastushenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2014.09.003_bib0005","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1468-3083.2010.03613.x","article-title":"Combining etanercept with traditional agents in the treatment of psoriasis: A review of the clinical evidence","volume":"24","author":"Foley","year":"2010","journal-title":"J Eur Acad Derm Venereol"},{"key":"10.1016\/j.ad.2014.09.003_bib0010","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0190-9622(03)01144-7","article-title":"Combining the new biologic agents with our current psoriasis armamentarium","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.sder.2010.03.003","article-title":"Combining traditional systemic and biologic therapies for psoriasis","volume":"29","author":"Heffernan","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.ad.2014.09.003_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/JIR.S4405","article-title":"Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update","volume":"2","author":"Segaert","year":"2009","journal-title":"J Inflamm Res"},{"issue":"Suppl 1","key":"10.1016\/j.ad.2014.09.003_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0001-7310(10)70007-7","article-title":"Combined therapy with etanercept and systemic drugs or phototherapy","volume":"101","author":"Belinch\u00f3n","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2014.09.003_bib0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","article-title":"Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis","volume":"349","author":"Heydendael","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2014.09.003_bib0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2014.09.003_bib0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.21655","article-title":"Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthitis Rheum"},{"key":"10.1016\/j.ad.2014.09.003_bib0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","article-title":"Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial","volume":"372","author":"Emery","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2014.09.003_bib0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/09546630600967166","article-title":"Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study","volume":"17","author":"Gottlieb","year":"2006","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.ad.2014.09.003_bib0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-4632.2008.03419.x","article-title":"Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis","volume":"47","author":"Yamauchi","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2340\/00015555-0511","article-title":"The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy","volume":"88","author":"Zachariae","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2014.09.003_bib0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2133.2008.08669.x","article-title":"Etanercept combined with methotrexate for high-need psoriasis","volume":"159","author":"Driessen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0075","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.2012.11015.x","article-title":"A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis","volume":"167","author":"Gottlieb","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0080","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/ard.2007.073544","article-title":"Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group Register","volume":"67","author":"Kristensen","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ad.2014.09.003_bib0085","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2133.2011.10213.x","article-title":"Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris","volume":"164","author":"Gniadecki","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","article-title":"Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry","volume":"69","author":"Greenberg","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2014.09.003_bib0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2133.1999.02765.x","article-title":"Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acictretin","volume":"140","author":"McKenna","year":"1999","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.ad.2014.09.003_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/jdt.14.s2.3.6","article-title":"Acitretin suppression of squamous cell carcinoma: Case report and literature review","volume":"14","author":"Lebwohl","year":"2003","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.ad.2014.09.003_bib0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaad.2011.07.040","article-title":"Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis","volume":"67","author":"Pariser","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0110","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1365-2133.2008.08564.x","article-title":"Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: A 24-week, randomized, controlled, investigator-blinded pilot trial","volume":"158","author":"Gisondi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-4632.2008.03470.x","article-title":"Combining systemic retinoids with biologic agents for moderate to severe psoriasis","volume":"47","author":"Smith","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0120","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1468-3083.2008.03053.x","article-title":"Palmoplantar pustulosis with arthro-osteitis: Successful treatment with etanercept and acitretin","volume":"23","author":"Antoniou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2014.09.003_bib0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2007.11.006","article-title":"Systemic therapies for psorisis: Methotrexate, retinoids, and cyclosporine","volume":"26","author":"Warren","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/ard.2009.119446","article-title":"Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis","volume":"69","author":"D\u2019Angelo","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2014.09.003_bib0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5021\/ad.2010.22.2.138","article-title":"A clinical trial of combination therapy with etanercept and low dose cyclosporine for the treatment of refractory psoriasis","volume":"22","author":"Lee","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0140","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/ard.2010.130864","article-title":"Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: A randomised pilot study","volume":"70","author":"Atzeni","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2014.09.003_bib0145","first-page":"245","article-title":"Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): Efficacy, safety, and patient-reported outcomes","volume":"7","author":"Kircik","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2008.08926.x","article-title":"Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept","volume":"160","author":"Wolf","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0155","doi-asserted-by":"crossref","unstructured":"Inzinger M, Legat FJ, Hofer A, Weger W, Gruber-Wackernagel A, Salmhofer W, et al. Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents. Br J Dermatol. 2014; 171:915-7.","DOI":"10.1111\/bjd.12992"},{"key":"10.1016\/j.ad.2014.09.003_bib0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1684\/ejd.2011.1330","article-title":"Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis","volume":"21","author":"De Simone","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0165","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1365-2133.2011.10358.x","article-title":"Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks","volume":"164","author":"Gambichler","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/09546634.2011.607795","article-title":"A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept","volume":"23","author":"Lynde","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2014.09.003_bib0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1468-3083.2012.04611.x","article-title":"A randomized, \u201chead-to-head\u201d pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients","volume":"27","author":"Park","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2014.09.003_bib0180","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.jaad.2005.11.1088","article-title":"Efficacy of etanercept in an integrated multistudy database of patients with psoriasis","volume":"54","author":"Gordon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0185","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1468-3083.2011.04065.x","article-title":"Obesity and psoriasis: Body weight and body mass index influence the response to biological treatment","volume":"25","author":"Puig","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2014.09.003_bib0190","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2014.09.003_bib0195","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1365-2133.2005.06688.x","article-title":"A global phase iii randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction","volume":"152","author":"Papp","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bjd.12277","article-title":"Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis","volume":"169","author":"Calzavara-Pinton","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2014.09.003_bib0205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jdv.12118","article-title":"A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis","volume":"28","author":"Mrowietz","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731014004189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731014004189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:03:34Z","timestamp":1757552614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731014004189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0001731014004189"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2014.09.003","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento combinado con etanercept y f\u00e1rmacos sist\u00e9micos\/fototerapia en psoriasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2014.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}